Content from Coultreon
The team supplied the copy and photography and helped shape the structure of every page.
A website that grows with a biotech company.
Coultreon Biopharma is a biotech company based in Leuven. Tixer first built the Onco3R Therapeutics website and, after the name change, the new Coultreon site. We continue to work together.
Built around your story
Coultreon Biopharma
Design and build · CMS · Press releases · SEO · Ongoing partnership
The question: a new name, a new website
Coultreon Biopharma is a clinical-stage biotech company developing oral medicines for chronic inflammatory and autoimmune diseases. Our work together began with the Onco3R Therapeutics website. When the company continued as Coultreon, it needed a new site that brought its new identity and scientific story together clearly.
The audience is broad: partners, investors, researchers and candidates. They need to follow the science quickly and find the company's news.
- Design and build
- CMS
- Press releases
- SEO
- Ongoing partnership
The solution: clear, discoverable and easy to manage
Tixer handled the design, build and technology. Coultreon provided the copy and photography. The site explains the science, from pipeline to clinical results, and was set up from the ground up to be found.
SEO as part of the build
A CMS for presentations and vacancies
A recognisable presentation for partners and investors
Built together
Coultreon was closely involved in building the site. The content stayed with the people who know the science, and Tixer made sure that content came across well.
Design and build by Tixer
We translated the new identity into a design and built the site, including SEO and technology.
Short lines
Questions and decisions were discussed directly, without intermediaries.
After launch: a site that stays current
A biotech company never stands still, and neither does its website. Through the CMS, Coultreon updates its presentations and vacancies itself. We turn new press releases into polished web pages.
Presentations
The team publishes new presentations itself through the CMS.
Vacancies
New roles go live quickly, without needing a developer.
Press releases
We turn every press release into a polished web page, with a layout that suits its content.
A partnership that continues
Our work together started in the days of Onco3R Therapeutics and continues at Coultreon Biopharma. We keep providing support, making changes and publishing news, so the website grows along with the company.
Visit Coultreon Biopharma
Explore the Coultreon Biopharma website.
Visit the website: Visit Coultreon BiopharmaFrequently asked questions
Clear answers to common questions.
What did Tixer develop for Coultreon Biopharma?
First the Onco3R Therapeutics website, then a new website after the name change to Coultreon Biopharma. Tixer handled design, build, SEO and technology; Coultreon provided the copy and photography.
What can Coultreon update itself?
Through the CMS, the team manages the presentations and vacancies on the website.
How are the press releases published?
Tixer turns every press release into a web page with a layout that suits its content.
Does Tixer stay involved after launch?
Yes. We work together continuously on support, changes and new content.
A website that grows with your business?
Tell us about your website and what you need after launch. Together we agree on management, content and ongoing development.